唾液腺肿瘤病理诊断规范

2021-03-30 中华口腔医学会 中华病理学杂志.2021.50(3):185-189.

唾液腺肿瘤种类繁多,规范化的唾液腺肿瘤病理诊断报告是患者治疗策略选择和预后评估的重要依据。由中华口腔医学会口腔病理学专业委员会牵头病理及相关专业专家,制定了唾液腺肿瘤病理标本固定、取材及报告内容等的规

中文标题:

唾液腺肿瘤病理诊断规范

发布机构:

中华口腔医学会

发布日期:

2021-03-30

简要介绍:

唾液腺肿瘤种类繁多,规范化的唾液腺肿瘤病理诊断报告是患者治疗策略选择和预后评估的重要依据。由中华口腔医学会口腔病理学专业委员会牵头病理及相关专业专家,制定了唾液腺肿瘤病理标本固定、取材及报告内容等的规范。本规范反映了2017版WHO唾液腺肿瘤分类中的一些变化,包含了与肿瘤诊断、治疗相关的较为特异性的免疫组织化学及分子检测指标等。该规范的制定旨在提高我国唾液腺肿瘤病理报告质量、优化患者临床治疗实践及预后评估。

下载附件:

(因为版权问题,不支持下载)

评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1209892, encodeId=cc8f120989220, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10448105680, createdName=ms5000000621806620, createdTime=Sat Apr 09 21:25:07 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081285, encodeId=58e41081285ca, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dec22608622, createdName=gujie_happy, createdTime=Fri Dec 17 21:07:10 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1050061, encodeId=a37310500615c, content=细化了包膜内癌与包膜累及概念。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201024/67558ad1510145499d4ffbb4720a49f0/db11b160e7384fb99f31c2853d79dc4c.jpg, createdBy=74815279084, createdName=薛鹏, createdTime=Mon Sep 13 21:43:54 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003105, encodeId=bc3f10031051c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84fb1997654, createdName=youngest, createdTime=Tue Jul 27 20:02:39 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001686, encodeId=e6ba100168699, content=已读,这也是受益匪浅呀!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79b75554426, createdName=cyjen, createdTime=Thu Jul 22 14:14:23 CST 2021, time=2021-07-22, status=1, ipAttribution=)]
    2022-04-09 ms5000000621806620

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1209892, encodeId=cc8f120989220, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10448105680, createdName=ms5000000621806620, createdTime=Sat Apr 09 21:25:07 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081285, encodeId=58e41081285ca, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dec22608622, createdName=gujie_happy, createdTime=Fri Dec 17 21:07:10 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1050061, encodeId=a37310500615c, content=细化了包膜内癌与包膜累及概念。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201024/67558ad1510145499d4ffbb4720a49f0/db11b160e7384fb99f31c2853d79dc4c.jpg, createdBy=74815279084, createdName=薛鹏, createdTime=Mon Sep 13 21:43:54 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003105, encodeId=bc3f10031051c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84fb1997654, createdName=youngest, createdTime=Tue Jul 27 20:02:39 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001686, encodeId=e6ba100168699, content=已读,这也是受益匪浅呀!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79b75554426, createdName=cyjen, createdTime=Thu Jul 22 14:14:23 CST 2021, time=2021-07-22, status=1, ipAttribution=)]
    2021-12-17 gujie_happy

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1209892, encodeId=cc8f120989220, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10448105680, createdName=ms5000000621806620, createdTime=Sat Apr 09 21:25:07 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081285, encodeId=58e41081285ca, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dec22608622, createdName=gujie_happy, createdTime=Fri Dec 17 21:07:10 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1050061, encodeId=a37310500615c, content=细化了包膜内癌与包膜累及概念。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201024/67558ad1510145499d4ffbb4720a49f0/db11b160e7384fb99f31c2853d79dc4c.jpg, createdBy=74815279084, createdName=薛鹏, createdTime=Mon Sep 13 21:43:54 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003105, encodeId=bc3f10031051c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84fb1997654, createdName=youngest, createdTime=Tue Jul 27 20:02:39 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001686, encodeId=e6ba100168699, content=已读,这也是受益匪浅呀!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79b75554426, createdName=cyjen, createdTime=Thu Jul 22 14:14:23 CST 2021, time=2021-07-22, status=1, ipAttribution=)]
    2021-09-13 薛鹏

    细化了包膜内癌与包膜累及概念。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1209892, encodeId=cc8f120989220, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10448105680, createdName=ms5000000621806620, createdTime=Sat Apr 09 21:25:07 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081285, encodeId=58e41081285ca, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dec22608622, createdName=gujie_happy, createdTime=Fri Dec 17 21:07:10 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1050061, encodeId=a37310500615c, content=细化了包膜内癌与包膜累及概念。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201024/67558ad1510145499d4ffbb4720a49f0/db11b160e7384fb99f31c2853d79dc4c.jpg, createdBy=74815279084, createdName=薛鹏, createdTime=Mon Sep 13 21:43:54 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003105, encodeId=bc3f10031051c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84fb1997654, createdName=youngest, createdTime=Tue Jul 27 20:02:39 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001686, encodeId=e6ba100168699, content=已读,这也是受益匪浅呀!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79b75554426, createdName=cyjen, createdTime=Thu Jul 22 14:14:23 CST 2021, time=2021-07-22, status=1, ipAttribution=)]
    2021-07-27 youngest

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1209892, encodeId=cc8f120989220, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10448105680, createdName=ms5000000621806620, createdTime=Sat Apr 09 21:25:07 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081285, encodeId=58e41081285ca, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dec22608622, createdName=gujie_happy, createdTime=Fri Dec 17 21:07:10 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1050061, encodeId=a37310500615c, content=细化了包膜内癌与包膜累及概念。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201024/67558ad1510145499d4ffbb4720a49f0/db11b160e7384fb99f31c2853d79dc4c.jpg, createdBy=74815279084, createdName=薛鹏, createdTime=Mon Sep 13 21:43:54 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003105, encodeId=bc3f10031051c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84fb1997654, createdName=youngest, createdTime=Tue Jul 27 20:02:39 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001686, encodeId=e6ba100168699, content=已读,这也是受益匪浅呀!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79b75554426, createdName=cyjen, createdTime=Thu Jul 22 14:14:23 CST 2021, time=2021-07-22, status=1, ipAttribution=)]
    2021-07-22 cyjen

    已读,这也是受益匪浅呀!

    0